1.98000 USD
0.09
4.35%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
1.98000
2.11000
Previous close
2.070000
Open
2.100000
Access this stock data via API
Subscribe
NRX Pharmaceuticals Inc.
1.98
0.09
4.35%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 6.2M 13.4M 17.0M 20.3M
Selling general and admin 13.5M 14.2M 27.3M 74.9M
Other operating expenses -1.2M 250K 20.6M
Operating income -18.5M -27.8M -44.3M -115.8M
Non operating interest income
Income 44K 494K 249K 0
Expense 230K 120K 0 18K
Other income expense -6.4M -2.7M 4.3M 22.8M
Pretax income -25.1M -30.2M -39.8M -93.1M
Tax provision 0 0
Net income -25.1M -30.2M -39.8M -93.1M
Basic EPS -2.4 -4 -6 -74.4
Diluted EPS -2.4 -4 -6 -74.4
Basic average shares 10.6M 7.6M 6.6M 4.7M
Diluted average shares 10.6M 7.6M 6.6M 4.7M
EBITDA -23.2M -30.0M -44.6M -115.8M
Net income from continuing op. -25.1M -30.2M -39.8M -93.1M
Minority interests
Preferred stock dividends 0 9K 0 255.8M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 13 minutes

20:46
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).